ASCO 2013 Annual Meeting Public Saturday - ASCO


Powered by SmugMug Log In
Chicago, IL - ASCO 2013 Annual Meeting: - Ryan B. Corcoran, MD, PhD, during "#3507 Ryan B. Corcoran, MD, PhDPharmacodynamic and efficacy analysis of the BRAF inhibitor dabrafenib (GSK436) in combination with the MEK inhibitor trametinib (GSK212) in patients with BRAFV600 mutant colorectal cancer (CRC). " at the American Society for Clinical Oncology (ASCO) Annual Meeting here today, Saturday June 1, 2013.  Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the meeting which is being held at the McCormick Convention center and features the latest cancer research in the areas of basic and clinical science. Photo by © ASCO/Brian Powers 2013 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org

Chicago, IL - ASCO 2013 Annual Meeting: - Ryan B. Corcoran, MD, PhD, during "#3507 Ryan B. Corcoran, MD, PhDPharmacodynamic and efficacy analysis of the BRAF inhibitor dabrafenib (GSK436) in combination with the MEK inhibitor trametinib (GSK212) in patients with BRAFV600 mutant colorectal cancer (CRC). " at the American Society for Clinical Oncology (ASCO) Annual Meeting here today, Saturday June 1, 2013. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the meeting which is being held at the McCormick Convention center and features the latest cancer research in the areas of basic and clinical science. Photo by © ASCO/Brian Powers 2013 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org